ArticleThe Lancet regional health. Western Pacific2023

Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial.

Fuxiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.